image credit- shutterstock
SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, has announced partnership with South Korea-based Lunit, a global leader in artificial intelligence (AI)-driven cancer diagnostics and therapeutics, to bring a new era of AI-powered breast cancer detection to patients across the country. The partnership marks a major milestone in SimonMed's mission to save lives through early detection.
Lunit INSIGHT DBT is trained on millions of images and engineered to detect even the most subtle signs of breast cancer, improving both sensitivity and specificity. Integrated into SimonMed's national network of over 170 accredited centers and supported by more than 200 subspecialty-trained radiologists, this AI solution helps ensure earlier detection, faster turnaround times, and actionable insights for patients.
